Veran Medical Technologies, Inc. Sustainability Profile
Veran Medical Technologies, Inc., a leading innovator in the medical technology sector, is headquartered in the United States. Founded in 2004, the company has made significant strides in the field of interventional pulmonology, focusing on advanced imaging and navigation solutions for lung cancer diagnosis and treatment. Veran's flagship product, the SPiN Thoracic Navigation System, stands out for its precision and ease of use, enabling healthcare professionals to perform minimally invasive procedures with enhanced accuracy. The company has established a strong market position, recognised for its commitment to improving patient outcomes through cutting-edge technology. With a growing presence in major operational regions across North America and beyond, Veran Medical Technologies continues to lead the way in transforming lung care.
DitchCarbon Score
How does Veran Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Veran Medical Technologies, Inc.'s score of 89 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Veran Medical Technologies, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Olympus Corporation, which influences its climate commitments and initiatives. While Veran Medical Technologies has not set its own reduction targets, it inherits sustainability initiatives from Olympus Corporation, which is committed to various climate pledges and frameworks. These include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded to Veran at a level 2 relationship. As part of its corporate family, Veran aligns with Olympus's broader sustainability goals, which focus on reducing emissions across all scopes, although specific targets and achievements have not been detailed for Veran itself. The company is expected to adhere to the climate strategies and commitments established by its parent organisation, Olympus Corporation, as it works towards enhancing its environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 26,266,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 101,475,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000 | 00,000 | 00,000 | 00,000 | - |
| Scope 3 | - | - | - | - | - | 00,000,000 | - | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Veran Medical Technologies, Inc.'s Industry?
How Carbon Intensive is Veran Medical Technologies, Inc.'s Location?
Veran Medical Technologies, Inc.'s Scope 3 Categories Breakdown
Veran Medical Technologies, Inc.'s Scope 3 emissions, which increased by 1% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 67% of Scope 3 emissions.
Top Scope 3 Categories
Veran Medical Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Veran Medical Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
